Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Rhabdoid Tumor 1Central Nervous System Neoplasms 1

Interventions

thymoglobulin 1selinexor 1fludarabine phosphate 1Thiotepa 1Tacrolimus 1Stem Cell Transplantation 1Radiotherapy 1RG7388 1Neoadjuvant Therapy 1Mycophenolic Acid 1Melphalan 1Hematopoietic Stem Cell Transplantation 1Etoposide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Rhabdoid Tumor × RG7388 × Clear all
NCT05952687 2024-03-27

Trial of Idasanutlin and Selinexor Therapy for Children With Progressive/Relapsed AT/RT or Extra-CNS Malignant Rhabdoid Tumors

St. Jude Children's Research Hospital

Phase 1 Withdrawn
CNS

Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡